Institutional Investors Sentiment Indicator of Natus Medical Inc (NASDAQ:BABY) Increases in Q4 2016

July 17, 2017 - By Winifred Garcia

 Institutional Investors Sentiment Indicator of Natus Medical Inc (NASDAQ:BABY)  Increases in  Q4 2016

Sentiment for Natus Medical Inc (NASDAQ:BABY)

Natus Medical Inc (NASDAQ:BABY) institutional sentiment increased to 1.93 in 2016 Q4. Its up 0.82, from 1.11 in 2016Q3. The ratio has improved, as 129 active investment managers opened new or increased stock positions, while 67 trimmed and sold stock positions in Natus Medical Inc. The active investment managers in our partner’s database now possess: 29.10 million shares, up from 27.36 million shares in 2016Q3. Also, the number of active investment managers holding Natus Medical Inc in their top 10 stock positions was flat from 2 to 2 for the same number . Sold All: 11 Reduced: 56 Increased: 78 New Position: 51.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.27 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 34.71 P/E ratio.

About 358,628 shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since July 17, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Wall Street await Natus Medical Inc (NASDAQ:BABY) to release earnings on July, 19. Analysts forecast EPS of $0.33, down exactly $0.06 or 15.38 % from 2014’s $0.39 EPS. The expected BABY’s profit could reach $11.12M giving the stock 28.56 P/E in the case that $0.33 earnings per share is reported. After posting $0.30 EPS for the previous quarter, Natus Medical Inc’s analysts now forecast 10.00 % EPS growth.

Lyon Street Capital Llc holds 8.11% of its portfolio in Natus Medical Inc for 456,016 shares. Motley Fool Asset Management Llc owns 375,741 shares or 2.9% of their US portfolio. Moreover, Beddow Capital Management Inc has 2.57% invested in the company for 185,390 shares. The Delaware-based Ashford Capital Management Inc has invested 1.94% in the stock. Sio Capital Management Llc, a New York-based fund reported 90,865 shares.#img1#

Since January 1, 0001, it had 2 insider buys, and 3 sales for $190,940 activity.

Natus Medical Inc (NASDAQ:BABY) Ratings Coverage

Ratings analysis reveals 75% of Natus Medical’s analysts are positive. Out of 4 Wall Street analysts rating Natus Medical, 3 give it “Buy”, 0 “Sell” rating, while 1 recommend “Hold”. The lowest target is $39 while the high is $55. The stock’s average target of $48.67 is 29.10% above today’s ($37.7) share price. BABY was included in 8 notes of analysts from July 23, 2015. The company was downgraded on Thursday, February 2 by Raymond James. The rating was initiated by Benchmark on Tuesday, October 4 with “Buy”. The rating was upgraded by Raymond James on Tuesday, September 13 to “Outperform”. The stock has “Buy” rating by Roth Capital on Friday, June 23. TH Capital maintained Natus Medical Inc (NASDAQ:BABY) on Tuesday, January 12 with “Buy” rating. The rating was maintained by TH Capital on Thursday, October 22 with “Buy”. Roth Capital maintained Natus Medical Inc (NASDAQ:BABY) rating on Tuesday, April 5. Roth Capital has “Buy” rating and $39 target. The firm has “Buy” rating by TH Capital given on Thursday, July 23.

More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: “Natus Medical Incorporated in 4 Charts” on December 05, 2016, also Nasdaq.com with their article: “Natus Medical Inc (BABY) President and CEO James B Hawkins Bought $135920 of …” published on June 16, 2017, Fool.com published: “Natus Medical Inc. Fell 11% in April. Here’s Why.” on May 08, 2017. More interesting news about Natus Medical Inc (NASDAQ:BABY) were released by: Globenewswire.com and their article: “Lawsuit for Investors in Natus Medical Inc (NASDAQ:BABY) shares announced by …” published on February 06, 2017 as well as Fool.com‘s news article titled: “Why Natus Medical Inc Slipped Today” with publication date: September 26, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.